{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T05:28:12Z","timestamp":1794288492951,"version":"4.9.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Rapidly evolving viral pathogens such as SARS-CoV-2 continuously accumulate amino acid changes, some of which affect transmissibility, virulence or improve the virus\u2019 ability to escape host immunity. Since the beginning of the SARS-CoV-2 pandemic, multiple lineages with concerning phenotypic alterations, so-called Variants of Concern (VOCs), have emerged and risen to predominance. To optimize public health management and ensure the continued efficacy of vaccines, the early detection of such variants is essential. Therefore, large-scale viral genomic surveillance programs have been initiated worldwide, with data being deposited in public repositories in a timely manner. However, technologies for their continuous interpretation are lacking. Here, we describe the CoVerage system (\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.sarscoverage.org\" ext-link-type=\"uri\">www.sarscoverage.org<\/jats:ext-link>\n                    ) for viral genomic surveillance, which continuously predicts and characterizes emerging potential Variants of Interest (pVOIs) from country-wise lineage frequency dynamics, together with their antigenic and evolutionary alterations utilizing the GISAID viral genome resource. In a comprehensive assessment of VOIs, VUMs, and VOCs, we demonstrate how CoVerage can be used to swiftly identify and characterize such variants, with a lead time of almost three months relative to their WHO designation. CoVerage can facilitate the timely identification and assessment of future SARS-CoV-2 variants relevant for public health.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-60231-4","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T06:18:02Z","timestamp":1751955482000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["In silico genomic surveillance by CoVerage predicts and characterizes SARS-CoV-2 variants of interest"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3593-0628","authenticated-orcid":false,"given":"Katrina","family":"Norwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Luo","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Reimering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Hadi","family":"Foroughmand-Araabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sama","family":"Goliaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7090-8717","authenticated-orcid":false,"given":"Martin","family":"H\u00f6lzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9613-182X","authenticated-orcid":false,"given":"Frank","family":"Klawonn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2370-3430","authenticated-orcid":false,"given":"Alice C.","family":"McHardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"60231_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265\u2013269 (2020).","journal-title":"Nature"},{"key":"60231_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"E Dong","year":"2020","unstructured":"Dong, E., Du, H. & Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 20, 533\u2013534 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"60231_CR3","doi-asserted-by":"publisher","first-page":"115094","DOI":"10.1016\/j.diagmicrobio.2020.115094","volume":"98","author":"E Ortiz-Prado","year":"2020","unstructured":"Ortiz-Prado, E. et al. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn. Microbiol. Infect. Dis. 98, 115094 (2020).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"60231_CR4","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.cell.2020.09.018","volume":"183","author":"H Yao","year":"2020","unstructured":"Yao, H. et al. Molecular architecture of the SARS-CoV-2 virus. Cell 183, 730\u2013738.e13 (2020).","journal-title":"Cell"},{"key":"60231_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-021-03426-1","volume":"593","author":"NG Davies","year":"2021","unstructured":"Davies, N. G. et al. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7. Nature 593, 270\u2013274 (2021).","journal-title":"Nature"},{"key":"60231_CR6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1126\/science.abh2644","volume":"372","author":"NR Faria","year":"2021","unstructured":"Faria, N. R. et al. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science 372, 815\u2013821 (2021).","journal-title":"Science"},{"key":"60231_CR7","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1016\/j.cell.2021.04.006","volume":"184","author":"WF Garcia-Beltran","year":"2021","unstructured":"Garcia-Beltran, W. F. et al. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell 184, 2523 (2021).","journal-title":"Cell"},{"key":"60231_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41586-021-03470-x","volume":"593","author":"E Volz","year":"2021","unstructured":"Volz, E. et al. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature 593, 266\u2013269 (2021).","journal-title":"Nature"},{"key":"60231_CR9","doi-asserted-by":"publisher","first-page":"2068883","DOI":"10.1080\/21645515.2022.2068883","volume":"18","author":"M Dhawan","year":"2022","unstructured":"Dhawan, M. et al. Delta variant (B.1.617.2) of SARS-CoV-2: mutations, impact, challenges and possible solutions. Hum. Vaccin. Immunother. 18, 2068883 (2022).","journal-title":"Hum. Vaccin. Immunother."},{"key":"60231_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","volume":"19","author":"WT Harvey","year":"2021","unstructured":"Harvey, W. T. et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. 19, 409\u2013424 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"60231_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41579-022-00809-7","volume":"21","author":"M Cox","year":"2023","unstructured":"Cox, M. et al. SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies. Nat. Rev. Microbiol. 21, 112\u2013124 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"60231_CR12","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1002\/jmv.27643","volume":"94","author":"D Tian","year":"2022","unstructured":"Tian, D., Sun, Y., Xu, H. & Ye, Q. The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant. J. Med. Virol. 94, 2376\u20132383 (2022).","journal-title":"J. Med. Virol."},{"key":"60231_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.578","volume":"5","author":"B Hong","year":"2024","unstructured":"Hong, B., Li, M. & Fan, H. SARS-CoV-2 Omicron subvariants from BA.2 to BA.2.86 and JN.1: strong lung infection ability and evolving immune escape capacity. MedComm 5, e578 (2024).","journal-title":"MedComm"},{"key":"60231_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109904","volume":"27","author":"L Zhang","year":"2024","unstructured":"Zhang, L. et al. Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion. iScience 27, 109904 (2024).","journal-title":"iScience"},{"key":"60231_CR15","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3390\/genes15070876","volume":"15","author":"N Sitharam","year":"2024","unstructured":"Sitharam, N. et al. SARS-CoV-2 genomic epidemiology dashboards: a review of functionality and technological frameworks for the public health response. Genes15, 876 (2024).","journal-title":"Genes"},{"key":"60231_CR16","unstructured":"Statement on the antigen composition of COVID-19 vaccines. WHO https:\/\/www.who.int\/news\/item\/26-04-2024-statement-on-the-antigen-composition-of-covid-19-vaccines (2024)."},{"key":"60231_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18791-z","volume":"8","author":"TR Klingen","year":"2018","unstructured":"Klingen, T. R. et al. Sweep dynamics (SD) plots: computational identification of selective sweeps to monitor the adaptation of influenza A viruses. Sci. Rep. 8, 373 (2018).","journal-title":"Sci. Rep."},{"key":"60231_CR18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.46234\/ccdcw2021.255","volume":"3","author":"S Khare","year":"2021","unstructured":"Khare, S. et al. GISAID\u2019s role in pandemic response. China CDC Wkly 3, 1049\u20131051 (2021).","journal-title":"China CDC Wkly"},{"key":"60231_CR19","unstructured":"World Health Organization. WHO COVID-19 Dashboard. WHO COVID-19 Dashboard https:\/\/covid19.who.int (2023)."},{"key":"60231_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq909","volume":"39","author":"L Steinbr\u00fcck","year":"2011","unstructured":"Steinbr\u00fcck, L. & McHardy, A. C. Allele dynamics plots for the study of evolutionary dynamics in viral populations. Nucleic Acids Res. 39, e4 (2011).","journal-title":"Nucleic Acids Res."},{"key":"60231_CR21","doi-asserted-by":"publisher","first-page":"veab064","DOI":"10.1093\/ve\/veab064","volume":"7","author":"\u00c1 O\u2019Toole","year":"2021","unstructured":"O\u2019Toole, \u00c1 et al. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool. Virus Evol. 7, veab064 (2021).","journal-title":"Virus Evol."},{"key":"60231_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Stat. Methodol. 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol."},{"key":"60231_CR23","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1126\/science.1244730","volume":"342","author":"BF Koel","year":"2013","unstructured":"Koel, B. F. et al. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 342, 976\u2013979 (2013).","journal-title":"Science"},{"key":"60231_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1007892","volume":"16","author":"CM Saad-Roy","year":"2020","unstructured":"Saad-Roy, C. M. et al. Implications of localized charge for human influenza A H1N1 hemagglutinin evolution: insights from deep mutational scans. PLoS Comput. Biol. 16, e1007892 (2020).","journal-title":"PLoS Comput. Biol."},{"key":"60231_CR25","doi-asserted-by":"publisher","first-page":"e15674","DOI":"10.1371\/journal.pone.0015674","volume":"5","author":"N Arinaminpathy","year":"2010","unstructured":"Arinaminpathy, N. & Grenfell, B. Dynamics of glycoprotein charge in the evolutionary history of human influenza. PLoS ONE 5, e15674 (2010).","journal-title":"PLoS ONE"},{"key":"60231_CR26","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s15010-021-01677-8","volume":"49","author":"AM Almehdi","year":"2021","unstructured":"Almehdi, A. M. et al. SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies. Infection 49, 855\u2013876 (2021).","journal-title":"Infection"},{"key":"60231_CR27","doi-asserted-by":"crossref","unstructured":"Wang, W. et al. Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster sera. bioRxiv (2024).","DOI":"10.1101\/2024.04.05.588359"},{"key":"60231_CR28","doi-asserted-by":"publisher","unstructured":"Hodcroft, E. B. et al. Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677. medRxiv https:\/\/doi.org\/10.1101\/2021.02.12.21251658 (2021).","DOI":"10.1101\/2021.02.12.21251658"},{"key":"60231_CR29","unstructured":"SARS-CoV-2 variants of concern as of 31 January 2025. European Centre for Disease Prevention and Control https:\/\/www.ecdc.europa.eu\/en\/covid-19\/variants-concern (2021)."},{"key":"60231_CR30","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.immuni.2022.07.018","volume":"55","author":"K van der Straten","year":"2022","unstructured":"van der Straten, K. et al. Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron. Immunity 55, 1725\u20131731.e4 (2022).","journal-title":"Immunity"},{"key":"60231_CR31","first-page":"171","volume":"1","author":"F Wilcoxon","year":"1970","unstructured":"Wilcoxon, F., Katti, S. & Wilcox, R. A. Critical values and probability levels for the Wilcoxon rank sum test and the Wilcoxon signed rank test. Sel. Tables Math. Stat. 1, 171\u2013259 (1970).","journal-title":"Sel. Tables Math. Stat."},{"key":"60231_CR32","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41392-021-00809-8","volume":"6","author":"Y Gong","year":"2021","unstructured":"Gong, Y., Qin, S., Dai, L. & Tian, Z. The glycosylation in SARS-CoV-2 and its receptor ACE2. Signal. Transduct. Target. Ther. 6, 396 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"60231_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.239","volume":"4","author":"D Ao","year":"2023","unstructured":"Ao, D., He, X., Hong, W. & Wei, X. The rapid rise of SARS-CoV-2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants. MedComm 4, e239 (2023).","journal-title":"MedComm"},{"key":"60231_CR34","doi-asserted-by":"publisher","first-page":"nwae196","DOI":"10.1093\/nsr\/nwae196","volume":"11","author":"W Ma","year":"2024","unstructured":"Ma, W., Fu, H., Jian, F., Cao, Y. & Li, M. Distinct SARS-CoV-2 populational immune backgrounds tolerate divergent RBD evolutionary preferences. Natl. Sci. Rev. 11, nwae196 (2024).","journal-title":"Natl. Sci. Rev."},{"key":"60231_CR35","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2402880","volume":"13","author":"Q Wang","year":"2024","unstructured":"Wang, Q. et al. Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages. Emerg. Microbes Infect. 13, 2402880 (2024).","journal-title":"Emerg. Microbes Infect."},{"key":"60231_CR36","unstructured":"EG.5 Initial Risk Evaluation, 9 August 2023. WHO https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/09082023eg.5_ire_final.pdf (2023)."},{"key":"60231_CR37","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41586-023-06617-0","volume":"622","author":"NN Thadani","year":"2023","unstructured":"Thadani, N. N. et al. Learning from prepandemic data to forecast viral escape. Nature 622, 818\u2013825 (2023).","journal-title":"Nature"},{"key":"60231_CR38","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3390\/v13050935","volume":"13","author":"F Pucci","year":"2021","unstructured":"Pucci, F. & Rooman, M. Prediction and evolution of the molecular fitness of SARS-CoV-2 variants: introducing SpikePro. Viruses 13, 935 (2021).","journal-title":"Viruses"},{"key":"60231_CR39","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1126\/science.abm1208","volume":"376","author":"F Obermeyer","year":"2022","unstructured":"Obermeyer, F. et al. Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness. Science 376, 1327\u20131332 (2022).","journal-title":"Science"},{"key":"60231_CR40","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","volume":"603","author":"R Viana","year":"2022","unstructured":"Viana, R. et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature 603, 679\u2013686 (2022).","journal-title":"Nature"},{"key":"60231_CR41","unstructured":"World Health Organization. Update on Omicron. World Health Organization https:\/\/www.who.int\/news\/item\/28-11-2021-update-on-omicron (2021)."},{"key":"60231_CR42","unstructured":"World Health Organization. Historical working definitions and primary actions for SARS-CoV-2 variants. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/annex2_previous_vocs_and_definitions.pdf (2023)."},{"key":"60231_CR43","doi-asserted-by":"publisher","first-page":"e1010260","DOI":"10.1371\/journal.ppat.1010260","volume":"18","author":"A Mittal","year":"2022","unstructured":"Mittal, A., Khattri, A. & Verma, V. Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants. PLoS Pathog. 18, e1010260 (2022).","journal-title":"PLoS Pathog."},{"key":"60231_CR44","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.chom.2022.03.018","volume":"30","author":"KE Kistler","year":"2022","unstructured":"Kistler, K. E., Huddleston, J. & Bedford, T. Rapid and parallel adaptive mutations in spike S1 drive clade success in SARS-CoV-2. Cell Host Microbe 30, 545\u2013555.e4 (2022).","journal-title":"Cell Host Microbe"},{"key":"60231_CR45","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1126\/science.acx9738","volume":"374","author":"K Kupferschmidt","year":"2021","unstructured":"Kupferschmidt, K. Where did \u2018weird\u2019 Omicron come from?. Science 374, 1179 (2021).","journal-title":"Science"},{"key":"60231_CR46","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","volume":"608","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature 608, 593\u2013602 (2022).","journal-title":"Nature"},{"key":"60231_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28625","volume":"95","author":"F Scarpa","year":"2023","unstructured":"Scarpa, F. et al. Genome-based comparison between the recombinant SARS-CoV-2 XBB and its parental lineages. J. Med. Virol. 95, e28625 (2023).","journal-title":"J. Med. Virol."},{"key":"60231_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29359","volume":"96","author":"A Ciccozzi","year":"2024","unstructured":"Ciccozzi, A. et al. The mutation point of view of the SARS-CoV-2 HV.1 lineage. J. Med. Virol. 96, e29359 (2024).","journal-title":"J. Med. Virol."},{"key":"60231_CR49","first-page":"121","volume":"6","author":"\u00c1 O\u2019Toole","year":"2021","unstructured":"O\u2019Toole, \u00c1 et al. Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351\/501Y-V2. Wellcome Open Res. 6, 121 (2021).","journal-title":"Wellcome Open Res."},{"key":"60231_CR50","doi-asserted-by":"publisher","first-page":"veac024","DOI":"10.1093\/ve\/veac024","volume":"8","author":"M Giovanetti","year":"2022","unstructured":"Giovanetti, M. et al. Replacement of the Gamma by the Delta variant in Brazil: impact of lineage displacement on the ongoing pandemic. Virus Evol. 8, veac024 (2022).","journal-title":"Virus Evol."},{"key":"60231_CR51","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1097\/MS9.0000000000000469","volume":"85","author":"S Akash","year":"2023","unstructured":"Akash, S., Islam, M. R. & Dhama, K. Emergence BQ.1 and BQ.1.1 as newly identified omicron subvariants: current scenario and future outlook - an update. Ann. Med. Surg.85, 1329\u20131330 (2023).","journal-title":"Ann. Med. Surg."},{"key":"60231_CR52","unstructured":"Spread of the SARS-CoV-2 Omicron variant sub-lineage BQ.1 in the EU\/EEA. ECDC https:\/\/www.ecdc.europa.eu\/en\/publications-data\/spread-sars-cov-2-omicron-variant-sub-lineage-bq1-eueea (2022)."},{"key":"60231_CR53","unstructured":"XBB.1.5 Updated Risk Assessment, 20 June 2023. WHO https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/20230620xbb.1.5.pdf?sfvrsn=fff6f686_3 (2023)."},{"key":"60231_CR54","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41592-023-01769-3","volume":"20","author":"K Gangavarapu","year":"2023","unstructured":"Gangavarapu, K. et al. Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations. Nat. Methods 20, 512\u2013522 (2023).","journal-title":"Nat. Methods"},{"key":"60231_CR55","unstructured":"Statement on the antigen composition of COVID-19 vaccines. WHO https:\/\/www.who.int\/news\/item\/18-05-2023-statement-on-the-antigen-composition-of-covid-19-vaccines (2023)."},{"key":"60231_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24435-8","volume":"12","author":"AJ Greaney","year":"2021","unstructured":"Greaney, A. J. et al. Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies. Nat. Commun. 12, 4196 (2021).","journal-title":"Nat. Commun."},{"key":"60231_CR57","first-page":"e939580","volume":"29","author":"DV Parums","year":"2023","unstructured":"Parums, D. V. Editorial: the XBB.1.5 (\u2019Kraken\u2019) subvariant of Omicron SARS-CoV-2 and its rapid global spread. Med. Sci. Monit. 29, e939580 (2023).","journal-title":"Med. Sci. Monit."},{"key":"60231_CR58","doi-asserted-by":"crossref","unstructured":"Jeworowski, L. M. et al. Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023. Euro Surveill. 29, (2024).","DOI":"10.2807\/1560-7917.ES.2024.29.2.2300740"},{"key":"60231_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00813-7","volume":"24","author":"Y Kaku","year":"2024","unstructured":"Kaku, Y. et al. Virological characteristics of the SARS-CoV-2 JN.1 variant. Lancet Infect. Dis. 24, e82 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"60231_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.675","volume":"5","author":"Y Lu","year":"2024","unstructured":"Lu, Y., Ao, D., He, X. & Wei, X. The rising SARS-CoV-2 JN.1 variant: evolution, infectivity, immune escape, and response strategies. MedComm 5, e675 (2024).","journal-title":"MedComm"},{"key":"60231_CR61","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/S1473-3099(23)00744-2","volume":"24","author":"S Yang","year":"2024","unstructured":"Yang, S. et al. Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure. Lancet Infect. Dis. 24, e70\u2013e72 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"60231_CR62","doi-asserted-by":"publisher","first-page":"819","DOI":"10.15585\/mmwr.mm7337e2","volume":"73","author":"L Panagiotakopoulos","year":"2024","unstructured":"Panagiotakopoulos, L. et al. Use of COVID-19 vaccines for persons aged \u22656 months: recommendations of the Advisory Committee on Immunization Practices - United States, 2024-2025. MMWR Morb. Mortal. Wkly. Rep. 73, 819\u2013824 (2024).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"60231_CR63","doi-asserted-by":"publisher","first-page":"e1002492","DOI":"10.1371\/journal.pcbi.1002492","volume":"8","author":"L Steinbr\u00fcck","year":"2012","unstructured":"Steinbr\u00fcck, L. & McHardy, A. C. Inference of genotype-phenotype relationships in the antigenic evolution of human influenza A (H3N2) viruses. PLoS Comput. Biol. 8, e1002492 (2012).","journal-title":"PLoS Comput. Biol."},{"key":"60231_CR64","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1126\/science.abf3995","volume":"371","author":"MA Martin","year":"2021","unstructured":"Martin, M. A., VanInsberghe, D. & Koelle, K. Insights from SARS-CoV-2 sequences. Science 371, 466\u2013467 (2021).","journal-title":"Science"},{"key":"60231_CR65","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/s41587-021-01040-0","volume":"39","author":"K Kalia","year":"2021","unstructured":"Kalia, K., Saberwal, G. & Sharma, G. The lag in SARS-CoV-2 genome submissions to GISAID. Nat. Biotechnol. 39, 1058\u20131060 (2021).","journal-title":"Nat. Biotechnol."},{"key":"60231_CR66","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1093\/bioinformatics\/bty407","volume":"34","author":"J Hadfield","year":"2018","unstructured":"Hadfield, J. et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics 34, 4121\u20134123 (2018).","journal-title":"Bioinformatics"},{"key":"60231_CR67","doi-asserted-by":"publisher","first-page":"eabk3445","DOI":"10.1126\/scitranslmed.abk3445","volume":"14","author":"MC Maher","year":"2022","unstructured":"Maher, M. C. et al. Predicting the mutational drivers of future SARS-CoV-2 variants of concern. Sci. Transl. Med. 14, eabk3445 (2022).","journal-title":"Sci. Transl. Med."},{"key":"60231_CR68","unstructured":"Hodcroft, E. B. CoVariants: SARS-CoV-2 mutations and variants of interest. https:\/\/covariants.org\/ (2021)."},{"key":"60231_CR69","doi-asserted-by":"crossref","unstructured":"Chen, A. T., Altschuler, K., Zhan, S. H., Chan, Y. A. & Deverman, B. E. COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest. Elife 10, e63409 (2021).","DOI":"10.7554\/eLife.63409"},{"key":"60231_CR70","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1093\/bioinformatics\/btac411","volume":"38","author":"A Wittig","year":"2022","unstructured":"Wittig, A. et al. CovRadar: continuously tracking and filtering SARS-CoV-2 mutations for genomic surveillance. Bioinformatics 38, 4223\u20134225 (2022).","journal-title":"Bioinformatics"},{"key":"60231_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02426-8","volume":"22","author":"A Fritz","year":"2021","unstructured":"Fritz, A. et al. Haploflow: strain-resolved de novo assembly of viral genomes. Genome Biol. 22, 212 (2021).","journal-title":"Genome Biol."},{"key":"60231_CR72","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1214\/aos\/1013699998","volume":"29","author":"Y Benjamini","year":"2001","unstructured":"Benjamini, Y. & Yekutieli, D. The control of the false discovery rate in multiple testing under dependency. Ann. Stat. 29, 1165\u20131188 (2001).","journal-title":"Ann. Stat."},{"key":"60231_CR73","doi-asserted-by":"publisher","unstructured":"Wirth, W. & Duchene, S. GISAIDR: Programmatically interact with the GISAID databases. Zenodo. https:\/\/doi.org\/10.5281\/zenodo.6474693 (2022).","DOI":"10.5281\/zenodo.6474693"},{"key":"60231_CR74","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1093\/bioinformatics\/bts565","volume":"28","author":"L Fu","year":"2012","unstructured":"Fu, L., Niu, B., Zhu, Z., Wu, S. & Li, W. CD-HIT: accelerated for clustering the next-generation sequencing data. Bioinformatics 28, 3150\u20133152 (2012).","journal-title":"Bioinformatics"},{"key":"60231_CR75","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1093\/nar\/gkf436","volume":"30","author":"K Katoh","year":"2002","unstructured":"Katoh, K., Misawa, K., Kuma, K.-I. & Miyata, T. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res. 30, 3059\u20133066 (2002).","journal-title":"Nucleic Acids Res."},{"key":"60231_CR76","doi-asserted-by":"publisher","first-page":"e9490","DOI":"10.1371\/journal.pone.0009490","volume":"5","author":"MN Price","year":"2010","unstructured":"Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree 2-approximately maximum-likelihood trees for large alignments. PLoS ONE 5, e9490 (2010).","journal-title":"PLoS ONE"},{"key":"60231_CR77","unstructured":"Spearman Rank Correlation Coefficient. in The Concise Encyclopedia of Statistics 502\u2013505 (Springer New York, 2008)."},{"key":"60231_CR78","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/mco2.110","volume":"2","author":"X He","year":"2021","unstructured":"He, X., Hong, W., Pan, X., Lu, G. & Wei, X. SARS-CoV-2 Omicron variant: characteristics and prevention. MedComm. 2, 838\u2013845 (2021).","journal-title":"MedComm"},{"key":"60231_CR79","unstructured":"National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. SARS-CoV-2 variant classifications and definitions. https:\/\/stacks.cdc.gov\/view\/cdc\/133705 (2023)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60231-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60231-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60231-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T07:03:36Z","timestamp":1751958216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60231-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60231"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60231-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"28 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6281"}}